Van Eck Associates Corp Royalty Pharma PLC Transaction History
Van Eck Associates Corp
- $77.4 Billion
- Q1 2025
A detailed history of Van Eck Associates Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Van Eck Associates Corp holds 124,025 shares of RPRX stock, worth $4.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,025
Previous 127,140
2.45%
Holding current value
$4.6 Million
Previous $3.24 Million
19.03%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RPRX
# of Institutions
485Shares Held
282MCall Options Held
2.51MPut Options Held
940K-
Morgan Stanley New York, NY41MShares$1.52 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$853 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$497 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$451 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...